Doctor of Podiatric Medicine Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Anna Doan

Podiatrist, Foot & Ankle Surgery Washington, PA Doctor of Podiatric Medicine

NPI 1568044774 CMS profile 9723839

100 Adios Dr Ste 1100, Washington, PA 15301

Open in the dashboard

General payments

$9,089

80 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Anna Doan of Washington, PA is reported in the CMS Open Payments database as having received $9,089 across 80 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $197 8
2024 General $5,012 35
2023 General $1,616 21
2022 General $1,731 10
2021 General $533 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anna Doan
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Anna Doan were reported at $197. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Anna Doan Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $0 $389 $118–$1,406 $163
2020 $0 $191 $62–$691 $114
2021 $533 $329 $104–$1,341 $132
2022 $1,731 $419 $125–$1,611 $149
2023 $1,616 $377 $128–$1,164 $160
2024 $5,012 $394 $134–$1,168 $164
2025 $197 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Orthofix Medical, Inc. $3,492 30 payments
  2. Smith+Nephew, Inc. $2,430 17 payments
  3. Mid-Atlantic Surgical Systems, LLC $1,256 3 payments
  4. Integra LifeSciences Corporation $686 9 payments
  5. AbbVie, Inc. $208 2 payments
  6. Melinta Therapeutics, Inc. $183 2 payments
  7. Stryker Corporation $138 2 payments
  8. Horizon Therapeutics plc $135 2 payments
  9. Kerecis Limited $130 2 payments
  10. Bioventus LLC $105 2 payments
  11. Other $326 9 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Travel and Lodging $4,147 21 payments
  2. Food and Beverage $3,742 58 payments
  3. Education $1,200 1 payment
Products named General payments · program years 2021–2025
  1. TrueLok $4,398 41 payments
  2. PICO $1,083 6 payments
  3. OASIS $847 4 payments
  4. Versajet $847 4 payments
  5. ACTICOAT 4" X 4" $847 4 payments
  6. Allevyn Gentle Border 10 x 10cm Ctn 10 $847 4 payments
  7. GRAFIX $687 1 payment
  8. INTEGRA DERMAL REGENERATION TEMPLATE $686 9 payments
  9. PRIMATRIX $686 9 payments
  10. Integra $458 7 payments
  11. Other $4,232 61 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

76

Median for Podiatry: 160

Drug cost

$422

Median for Podiatry: $2,368

Branded share of claims

19.7%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ciclopirox Ciclopirox Olamine Brand 15 $145
Ciclopirox Generic 12 $110
Mupirocin Generic 13 $64
Doxycycline Hyclate Generic 24 $61
Methylprednisolone Generic 12 $43

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Records

80 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record